The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer
Clinical trial NCT05822726 · UNKNOWN
Trial details
- NCT number
- NCT05822726
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-09-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.